Get the Stockscreener App
27.84
1.00%
-0.28
Lakefront Biotherapeutics Nv Adr stock is traded at $27.84, with a volume of 167.21K.
It is down -1.00% in the last 24 hours and down -4.03% over the past month.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
See More
Previous Close:
$28.12
Open:
$28.19
24h Volume:
167.21K
Relative Volume:
1.22
Market Cap:
$1.82B
Revenue:
$1.21B
Net Income/Loss:
$570.23M
P/E Ratio:
3.2159
EPS:
8.6571
Net Cash Flow:
$-293.03M
1W Performance:
-7.23%
1M Performance:
-4.03%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$27.78
$28.37
1-Week Range:
$27.78
$30.25
52-Week Range:
$26.42
$30.91
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Company Profile
Name
Lakefront Biotherapeutics Nv Adr
Sector
Industry
Phone
-
Address
-
Compare LKFT vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LKFT
Lakefront Biotherapeutics Nv Adr
|
27.84 | 1.82B | 1.21B | 570.23M | -293.03M | 8.6571 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Latest News
argenx SE (ARGX) stock price, news, quote and history - Yahoo Finance UK
Lakefront Biotherapeutics director resigns for Sanofi role By Investing.com - Investing.com Nigeria
Lakefront Biotherapeutics director resigns for Sanofi role - Investing.com
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley - Investing.com South Africa
Galapagos Q1 2026 presentation: Ouro deal, rebranding highlight transformation - Investing.com
LKFTLakefront Biotherapeutics NV ADR Latest SEC Filings - Finviz
GXEA Forecast — Price Target — Prediction for 2027 - TradingView
Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com - Investing.com South Africa
Gilead and Lakefront complete Ouro Medicines acquisition - Investing.com
Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated - Bez Kabli
LKFT.AS Stock Price, Quote & Chart | LAKEFRONT BIOTHERAPEUTICS (AMS:LKFT) - ChartMill
Lakefront Receives Transparency Notification from Bank of America - Yahoo Finance Australia
LKFT Technical Analysis | Trend, Signals & Chart Patterns | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
LKFT Stock Chart | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
What is the current Price Target and Forecast for Lakefront BiotherapeuticsSponsored ADR (LKFT) - Zacks Investment Research
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com
LKFT: Lakefront BiotherapeuticsSponsored ADRCash Flow Statements - Zacks Investment Research
LKFT : Lakefront BiotherapeuticsSponsored Adr Key Company Details - Zacks Investment Research
Lakefront BiotherapeuticsSponsored ADR (LKFT) Return On Equity (TTM) - Zacks Investment Research
Lakefront Biotherapeutics NV Stock Baskets - GuruFocus
Lakefront Biotherapeutics (NASDAQ: GLPG) outlines ADR deposit terms - Stock Titan
LKFT Stock Price and Chart — NASDAQ:LKFT - TradingView
LKFT Stock Price and Chart — EURONEXT:LKFT - TradingView
Earnings call transcript: Galapagos Q1 2026 beats EPS, revenue falls short - Investing.com
Galapagos (GLPG) posts Q1 2026 profit and commits up to €790M to Ouro deal - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
ActivePassive International Equity ETF Holdings - Quiver Quantitative
Invesco NASDAQ Future Gen 200 ETF Holdings - Quiver Quantitative
Genmab A/S (GMAB) stock price, news, quote and history - Yahoo Finance UK
Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):